Global Biodegradable Stents Market Overview And Scope:
Global Biodegradable Stents Market Size was estimated at USD 867.74 million in 2022 and is projected to reach USD 2979.42 million by 2028, exhibiting a CAGR of 22.83% during the forecast period.
The Global Biodegradable Stents Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Biodegradable Stents utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Abbott Laboratories, Kyoto Medical Planning, Reva Medical, Elixir Medical Corporation, Amaranth Medical, Terumo Corporation, Arterius Limited, Biotronik, Xenogenics Corporation, Meril Life Sciences Pvt
Global Biodegradable Stents Market Segmentation
By Type, Biodegradable Stents market has been segmented into:Polymer Based Bioabsorbable Stents
Metal Based Bioabsorbable Stents
By Application, Biodegradable Stents market has been segmented into:
Coronary Artery Disease
Peripheral Artery Disease
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Biodegradable Stents market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Biodegradable Stents market.
Top Key Players Covered in Biodegradable Stents market are:
Abbott Laboratories
Kyoto Medical Planning
Reva Medical
Elixir Medical Corporation
Amaranth Medical
Terumo Corporation
Arterius Limited
Biotronik
Xenogenics Corporation
Meril Life Sciences Pvt
Objective to buy this Report:
1. Biodegradable Stents analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Biodegradable Stents market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Biodegradable Stents Market by Type
5.1 Biodegradable Stents Market Overview Snapshot and Growth Engine
5.2 Biodegradable Stents Market Overview
5.3 Polymer Based Bioabsorbable Stents
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Polymer Based Bioabsorbable Stents: Geographic Segmentation
5.4 Metal Based Bioabsorbable Stents
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Metal Based Bioabsorbable Stents: Geographic Segmentation
Chapter 6: Biodegradable Stents Market by Application
6.1 Biodegradable Stents Market Overview Snapshot and Growth Engine
6.2 Biodegradable Stents Market Overview
6.3 Coronary Artery Disease
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Coronary Artery Disease: Geographic Segmentation
6.4 Peripheral Artery Disease
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Peripheral Artery Disease: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Biodegradable Stents Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Biodegradable Stents Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Biodegradable Stents Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 ABBOTT LABORATORIES
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 KYOTO MEDICAL PLANNING
7.4 REVA MEDICAL
7.5 ELIXIR MEDICAL CORPORATION
7.6 AMARANTH MEDICAL
7.7 TERUMO CORPORATION
7.8 ARTERIUS LIMITED
7.9 BIOTRONIK
7.10 XENOGENICS CORPORATION
7.11 MERIL LIFE SCIENCES PVT
Chapter 8: Global Biodegradable Stents Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Polymer Based Bioabsorbable Stents
8.2.2 Metal Based Bioabsorbable Stents
8.3 Historic and Forecasted Market Size By Application
8.3.1 Coronary Artery Disease
8.3.2 Peripheral Artery Disease
Chapter 9: North America Biodegradable Stents Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Polymer Based Bioabsorbable Stents
9.4.2 Metal Based Bioabsorbable Stents
9.5 Historic and Forecasted Market Size By Application
9.5.1 Coronary Artery Disease
9.5.2 Peripheral Artery Disease
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Biodegradable Stents Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Polymer Based Bioabsorbable Stents
10.4.2 Metal Based Bioabsorbable Stents
10.5 Historic and Forecasted Market Size By Application
10.5.1 Coronary Artery Disease
10.5.2 Peripheral Artery Disease
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Biodegradable Stents Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Polymer Based Bioabsorbable Stents
11.4.2 Metal Based Bioabsorbable Stents
11.5 Historic and Forecasted Market Size By Application
11.5.1 Coronary Artery Disease
11.5.2 Peripheral Artery Disease
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Biodegradable Stents Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Polymer Based Bioabsorbable Stents
12.4.2 Metal Based Bioabsorbable Stents
12.5 Historic and Forecasted Market Size By Application
12.5.1 Coronary Artery Disease
12.5.2 Peripheral Artery Disease
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Biodegradable Stents Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Polymer Based Bioabsorbable Stents
13.4.2 Metal Based Bioabsorbable Stents
13.5 Historic and Forecasted Market Size By Application
13.5.1 Coronary Artery Disease
13.5.2 Peripheral Artery Disease
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Biodegradable Stents Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Polymer Based Bioabsorbable Stents
14.4.2 Metal Based Bioabsorbable Stents
14.5 Historic and Forecasted Market Size By Application
14.5.1 Coronary Artery Disease
14.5.2 Peripheral Artery Disease
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Biodegradable Stents Scope:
|
Report Data
|
Biodegradable Stents Market
|
|
Biodegradable Stents Market Size in 2025
|
USD XX million
|
|
Biodegradable Stents CAGR 2025 - 2032
|
XX%
|
|
Biodegradable Stents Base Year
|
2024
|
|
Biodegradable Stents Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Laboratories, Kyoto Medical Planning, Reva Medical, Elixir Medical Corporation, Amaranth Medical, Terumo Corporation, Arterius Limited, Biotronik, Xenogenics Corporation, Meril Life Sciences Pvt.
|
|
Key Segments
|
By Type
Polymer Based Bioabsorbable Stents
Metal Based Bioabsorbable Stents
By Applications
Coronary Artery Disease
Peripheral Artery Disease
|
